{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "RS",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "RS A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that the SL1 binding mode (residues 3-25 as a helix) is augmented by disease variants, leading to intermolecular interactions forming oligomers and fibrils.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links the SL1 mode to disease progression, aligning with the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses solution NMR to analyze lipid binding, a validated method for studying protein-lipid interactions.",
          "judgment": "Yes",
          "reasoning": "NMR is a standard technique for assessing protein-lipid interactions, making the assay applicable."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper includes multiple replicates and controls (wild-type RS, disease variants), confirming assay validity.",
          "judgment": "Yes",
          "reasoning": "The study provides both wild-type and disease variant controls, ensuring assay reliability."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The number of variant controls (3) is less than 11, and the variants show increased toxicity.",
          "judgment": "PS3_moderate",
          "reasoning": "With 3 controls (A30P, E46K, A53T), the odds path is calculated as moderate due to the increased toxicity observed in the variants."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The disease variants (A30P) exhibit increased toxicity due to the SL1 binding mode, which promotes intermolecular interactions and fibril formation. The evidence is moderate (PS3_moderate) based on limited controls (3 variants) but supports pathogenicity."
    },
    {
      "variant_id": {
        "Gene": "RS",
        "Protein_Change": {
          "ref": "A",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "RS E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper confirms the SL1 mode is more prevalent in E46K, contributing to disease progression.",
          "judgment": "Yes",
          "reasoning": "The SL1 mode's increased prevalence in E46K aligns with the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "NMR is used to analyze lipid binding, a validated method for this study.",
          "judgment": "Yes",
          "reasoning": "NMR is a standard technique for assessing protein-lipid interactions, making the assay applicable."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study includes multiple replicates and controls (wild-type RS, disease variants), confirming assay validity.",
          "judgment": "Yes",
          "reasoning": "The study provides both wild-type and disease variant controls, ensuring assay reliability."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The number of variant controls (3) is less than 11, and the variants show increased toxicity.",
          "judgment": "PS3_moderate",
          "reasoning": "With 3 controls (A30P, E46K, A53T), the odds path is calculated as moderate due to the increased toxicity observed in the variants."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The disease variant E46K exhibits increased toxicity due to the SL1 mode, which promotes intermolecular interactions and fibril formation. The evidence is moderate (PS3_moderate) based on limited controls (3 variants) but supports pathogenicity."
    },
    {
      "variant_id": {
        "Gene": "RS",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "RS A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that the SL1 mode is more prevalent in A53T, leading to disease progression.",
          "judgment": "Yes",
          "reasoning": "The SL1 mode's increased prevalence in A53T aligns with the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "NMR is used to analyze lipid binding, a validated method for this study.",
          "judgment": "Yes",
          "reasoning": "NMR is a standard technique for assessing protein-lipid interactions, making the assay applicable."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study includes multiple replicates and controls (wild-type RS, disease variants), confirming assay validity.",
          "judgment": "Yes",
          "reasoning": "The study provides both wild-type and disease variant controls, ensuring assay reliability."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The number of variant controls (3) is less than 11, and the variants show increased toxicity.",
          "judgment": "PS3_moderate",
          "reasoning": "With 3 controls (A30P, E46K, A53T), the odds path is calculated as moderate due to the increased toxicity observed in the variants."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The disease variant A53T exhibits increased toxicity due to the SL1 mode, which promotes intermolecular interactions and fibril formation. The evidence is moderate (PS3_moderate) based on limited controls (3 variants) but supports pathogenicity."
    }
  ]
}